BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 24.11.2014

New Clinical Trials Demographic Data; Availability for Comment

The Food and Drug Administration (FDA) is announcing the availability for public comment of Demographic Subgroup Data for FDA Approved Products on FDA's Internet Web site. This new posting implements Action 3.1 from Priority 3 of the Food and Drug Administration Safety and Innovation Act (FDASIA) Section 907 Action Plan designed to improve the availability and transparency of clinical trial demographic subgroup data. FDA is requesting comments on the format, content, and overall usability of the site to determine whether this approach is user friendly to the public.

Source: Federal Register — Food and Drug AdministrationOpen original release →